FindTrial
Sign In

Role of Coenzyme Q in ADHD in Children

Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04216186
Enrollment
40
Registered
2020-01-02
Start date
2018-11-01
Completion date
2030-12-01
Last updated
2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Brief summary

Role of Coenzyme Q in ADHD in Children

Detailed description

Role of Coenzyme Q in ADHD in Children: will it add a benefit?

Interventions

DRUGAtomoxetine

Atomoxetine once daily

DRUGCoenzyme Q

Coenzyme Q once daily

Sponsors

Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
2 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ADHD

Exclusion criteria

* Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with improved CONNERS scale6 monthsThe number of patients with improved CONNERS scale

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, ass. prof.
sheriefabdelsalam@yahoo.com00201147773440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026